Works matching AU Cook, Gordon

Results: 197
    1
    2
    3
    4
    5

    Toftanes: The Paleoecology of a Faroese Landnám Farm.

    Published in:
    Human Ecology: An Interdisciplinary Journal, 2005, v. 33, n. 5, p. 685, doi. 10.1007/s10745-005-4744-2
    By:
    • Vickers, Kim;
    • Bending, Joanna;
    • Buckland, Paul C.;
    • Edwards, Kevin J.;
    • Hansen, Steffen Stummann;
    • Cook, Gordon
    Publication type:
    Article
    6
    7
    8

    Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.

    Published in:
    Drugs, 2016, v. 76, n. 9, p. 989, doi. 10.1007/s40265-016-0590-3
    By:
    • Moreau, Philippe;
    • Donk, Niels;
    • Miguel, Jesus;
    • Lokhorst, Henk;
    • Nahi, Hareth;
    • Ben-Yehuda, Dina;
    • Cavo, Michele;
    • Cook, Gordon;
    • Delforge, Michel;
    • Einsele, Hermann;
    • Zweegman, Sonja;
    • Ludwig, Heinz;
    • Driessen, Christoph;
    • Palumbo, Antonio;
    • Facon, Thierry;
    • Plesner, Torben;
    • Dimopoulos, Meletios;
    • Sondergeld, Pia;
    • Sonneveld, Pieter;
    • Mateos, María-Victoria
    Publication type:
    Article
    9

    Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.

    Published in:
    Drugs, 2016, v. 76, n. 8, p. 853, doi. 10.1007/s40265-016-0573-4
    By:
    • Moreau, Philippe;
    • Donk, Niels;
    • Miguel, Jesus;
    • Lokhorst, Henk;
    • Nahi, Hareth;
    • Ben-Yehuda, Dina;
    • Cavo, Michele;
    • Cook, Gordon;
    • Delforge, Michel;
    • Einsele, Hermann;
    • Zweegman, Sonja;
    • Ludwig, Heinz;
    • Driessen, Christoph;
    • Palumbo, Antonio;
    • Facon, Thierry;
    • Plesner, Torben;
    • Dimopoulos, Meletios;
    • Sondergeld, Pia;
    • Sonneveld, Pieter;
    • Mateos, María-Victoria
    Publication type:
    Article
    10
    11

    Immune response to COVID‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response.

    Published in:
    British Journal of Haematology, 2022, v. 197, n. 3, p. 293, doi. 10.1111/bjh.18066
    By:
    • Ramasamy, Karthik;
    • Sadler, Ross;
    • Jeans, Sally;
    • Weeden, Paul;
    • Varghese, Sherin;
    • Turner, Alison;
    • Larham, Jemma;
    • Gray, Nathanael;
    • Carty, Oluremi;
    • Barrett, Joe;
    • Bowcock, Stella;
    • Oppermann, Udo;
    • Cook, Gordon;
    • Kyriakou, Chara;
    • Drayson, Mark;
    • Basu, Supratik;
    • Moore, Sally;
    • McDonald, Sarah;
    • Gooding, Sarah;
    • Javaid, Muhammad K.
    Publication type:
    Article
    12

    Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 4, p. 892, doi. 10.1111/bjh.17937
    By:
    • Booth, Stephen;
    • Curley, Helen M.;
    • Varnai, Csilla;
    • Arnold, Roland;
    • Lee, Lennard Y. W.;
    • Campton, Naomi A.;
    • Cook, Gordon;
    • Purshouse, Karin;
    • Aries, James;
    • Innes, Andrew;
    • Cook, Lucy B.;
    • Tomkins, Oliver;
    • Oram, Helen S.;
    • Tilby, Michael;
    • Kulasekararaj, Austin;
    • Wrench, David;
    • Dolly, Saoirse;
    • Newsom‐Davies, Tom;
    • Pettengell, Ruth;
    • Gault, Abigail
    Publication type:
    Article
    13

    Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 4, p. e33, doi. 10.1111/bjh.17903
    By:
    • Chan, Wei Yee;
    • Counsell, Nicholas;
    • de Tute, Ruth;
    • De‐Silva, Dunnya;
    • Phillips, Elizabeth H.;
    • Cavenagh, Jamie;
    • Adedayo, Toyin;
    • Braganca, Nivette;
    • Roddie, Claire;
    • Streetly, Matthew;
    • Schey, Stephen;
    • Koh, Mickey B.C.;
    • Crowe, Josephine;
    • Morris, Treen C.;
    • Cook, Gordon;
    • Clifton‐Hadley, Laura;
    • Rabin, Neil;
    • Owen, Roger G.;
    • Popat, Rakesh;
    • Yong, Kwee L.
    Publication type:
    Article
    14

    COVID symptoms, testing, shielding impact on patient‐reported outcomes and early vaccine responses in individuals with multiple myeloma.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 1, p. 95, doi. 10.1111/bjh.17764
    By:
    • Ramasamy, Karthik;
    • Sadler, Ross;
    • Jeans, Sally;
    • Varghese, Sherin;
    • Turner, Alison;
    • Larham, Jemma;
    • Gray, Nathanael;
    • Barrett, Joe;
    • Bowcock, Stella;
    • Cook, Gordon;
    • Kyriakou, Chara;
    • Smith, Dean;
    • Drayson, Mark;
    • Basu, Supratik;
    • Moore, Sally;
    • McDonald, Sarah;
    • Gooding, Sarah;
    • Javaid, Muhammad K.
    Publication type:
    Article
    15

    Health‐related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial.

    Published in:
    British Journal of Haematology, 2021, v. 194, n. 1, p. 132, doi. 10.1111/bjh.17435
    By:
    • Plesner, Torben;
    • Dimopoulos, Meletios A.;
    • Oriol, Albert;
    • San‐Miguel, Jesus;
    • Bahlis, Nizar J.;
    • Rabin, Neil;
    • Suzuki, Kenshi;
    • Yoon, Sung‐Soo;
    • Ben‐Yehuda, Dina;
    • Cook, Gordon;
    • Goldschmidt, Hartmut;
    • Grosicki, Sebastian;
    • Qin, Xiang;
    • Fastenau, John;
    • Garvin, Wendy;
    • Carson, Robin;
    • Renaud, Thomas;
    • Gries, Katharine S.
    Publication type:
    Article
    16

    Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 4, p. 750, doi. 10.1111/bjh.17377
    By:
    • Camilleri, Marquita;
    • Cuadrado, Maria;
    • Phillips, Elizabeth;
    • Wilson, William;
    • Jenner, Richard;
    • Pang, Gavin;
    • Kamora, Sumaiya;
    • Streetly, Matthew;
    • Popat, Rakesh;
    • Bygrave, Ceri;
    • Owen, Roger;
    • Cavenagh, James;
    • Chapman, Mike;
    • Sive, Jonathan;
    • Eccersley, Lydia;
    • Sheaff, Michael;
    • Benjamin, Reuben;
    • Ramasamy, Karthik;
    • Cook, Gordon;
    • Virchis, Andres
    Publication type:
    Article
    17

    Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. e19, doi. 10.1111/bjh.17391
    By:
    • Popat, Rakesh;
    • Counsell, Nicholas;
    • de Tute, Ruth;
    • De‐Silva, Dunnya;
    • Phillips, Elizabeth H.;
    • Cavenagh, Jamie D.;
    • Adedayo, Toyin;
    • Braganca, Nivette;
    • Roddie, Claire;
    • Streetly, Matthew;
    • Schey, Steve;
    • Koh, Mickey B. C.;
    • Crowe, Josephine;
    • Morris, Treen C.;
    • Cook, Gordon;
    • Smith, Paul;
    • Clifton‐Hadley, Laura;
    • Rabin, Neil;
    • Owen, Roger;
    • Yong, Kwee
    Publication type:
    Article
    18

    Early relapse after high‐dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high‐risk disease in multiple myeloma.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 551, doi. 10.1111/bjh.16793
    By:
    • Bygrave, Ceri;
    • Pawlyn, Charlotte;
    • Davies, Faith;
    • Craig, Zoe;
    • Cairns, David;
    • Hockaday, Anna;
    • Jenner, Matthew;
    • Cook, Gordon;
    • Drayson, Mark;
    • Owen, Roger;
    • Gregory, Walter;
    • Morgan, Gareth;
    • Jackson, Graham;
    • Kaiser, Martin
    Publication type:
    Article
    19

    Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open‐label, randomised, Phase III trial.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 5, p. 853, doi. 10.1111/bjh.16945
    By:
    • Jackson, Graham H.;
    • Pawlyn, Charlotte;
    • Cairns, David A.;
    • Striha, Alina;
    • Collett, Corinne;
    • Waterhouse, Anna;
    • Jones, John R.;
    • Wilson, Jamie;
    • Taylor, Craig;
    • Kishore, Bhuvan;
    • Garg, Mamta;
    • Williams, Cathy D.;
    • Karunanithi, Kamaraj;
    • Lindsay, Jindriska;
    • Jenner, Matthew W.;
    • Cook, Gordon;
    • Russell, Nigel H.;
    • Drayson, Mark T.;
    • Kaiser, Martin F.;
    • Owen, Roger G.
    Publication type:
    Article
    20
    21

    Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy.

    Published in:
    British Journal of Haematology, 2020, v. 190, n. 2, p. e83, doi. 10.1111/bjh.16874
    By:
    • Cook, Gordon;
    • John Ashcroft, A;
    • Pratt, Guy;
    • Popat, Rakesh;
    • Ramasamy, Karthik;
    • Kaiser, Martin;
    • Jenner, Matthew;
    • Henshaw, Sarah;
    • Hall, Rachel;
    • Sive, Jonathan;
    • Stern, Simon;
    • Streetly, Matthew;
    • Bygrave, Ceri;
    • Soutar, Richard;
    • Rabin, Neil;
    • Jackson, Graham H
    Publication type:
    Article
    22

    The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long‐term follow‐up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open‐label, phase 3 trial.

    Published in:
    British Journal of Haematology, 2019, v. 185, n. 3, p. 450, doi. 10.1111/bjh.15782
    By:
    • Parrish, Christopher;
    • Cook, Gordon;
    • Andrews, Vivienne E.;
    • Jenner, Matthew;
    • Yong, Kwee;
    • Cavet, Jim;
    • Hunter, Hannah;
    • Bird, Jenny M.;
    • Pratt, Guy;
    • Drayson, Mark T.;
    • Morris, Treen C. M.;
    • Royle, Kara‐Louise;
    • Cairns, David A.;
    • Hockaday, Anna;
    • Brown, Julia M.;
    • O'Connor, Sheila;
    • Ashcroft, A. John;
    • Williams, Cathy D.;
    • Cavenagh, Jamie D.;
    • Snowden, John A.
    Publication type:
    Article
    23

    Extended follow‐up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi‐centre phase I/II Clinical Trial).

    Published in:
    British Journal of Haematology, 2019, v. 185, n. 3, p. 573, doi. 10.1111/bjh.15551
    By:
    • Popat, Rakesh;
    • Yong, Kwee;
    • Brown, Sarah R.;
    • Flanagan, Louise;
    • Hall, Andrew;
    • Gregory, Walter;
    • Kishore, Bhuvan;
    • Streetly, Matthew;
    • Oakervee, Heather;
    • Cavenagh, Jamie;
    • Cook, Gordon;
    • Low, Eric
    Publication type:
    Article
    24
    25
    26
    27

    Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols.

    Published in:
    British Journal of Haematology, 2016, v. 172, n. 3, p. 360, doi. 10.1111/bjh.13802
    By:
    • Hough, Rachael;
    • Danby, Robert;
    • Russell, Nigel;
    • Marks, David;
    • Veys, Paul;
    • Shaw, Bronwen;
    • Wynn, Rob;
    • Vora, Ajay;
    • Mackinnon, Stephen;
    • Peggs, Karl S.;
    • Crawley, Charles;
    • Craddock, Charlie;
    • Pagliuca, Antonio;
    • Cook, Gordon;
    • Snowden, John A.;
    • Clark, Andrew;
    • Marsh, Judith;
    • Querol, Sergio;
    • Parkes, Guy;
    • Braund, Henny
    Publication type:
    Article
    28

    Unrelated Cord Blood Transplantation in adults: evolution, experience and long-term outcomes in the UK National Health Service : a retrospective analysis on behalf of the British Society of Blood and Marrow Transplantation and Eurocord.

    Published in:
    British Journal of Haematology, 2016, v. 172, n. 3, p. 478, doi. 10.1111/bjh.13913
    By:
    • Snowden, John A.;
    • Danby, Robert;
    • Ruggeri, Annalisa;
    • Marks, David I.;
    • Hough, Rachael E.;
    • Pagliuca, Antonio;
    • Potter, Michael;
    • Russell, Nigel;
    • Craddock, Charles;
    • Clark, Andrew;
    • Miller, Paul;
    • Cook, Gordon;
    • Gluckman, Eliane;
    • Shaw, Bronwen E.;
    • Rocha, Vanderson
    Publication type:
    Article
    29

    Optimizing the management of patients with spinal myeloma disease.

    Published in:
    British Journal of Haematology, 2015, v. 171, n. 3, p. 332, doi. 10.1111/bjh.13577
    By:
    • Molloy, Sean;
    • Lai, Maggie;
    • Pratt, Guy;
    • Ramasamy, Karthik;
    • Wilson, David;
    • Quraishi, Nasir;
    • Auger, Martin;
    • Cumming, David;
    • Punekar, Maqsood;
    • Quinn, Michael;
    • Ademonkun, Debo;
    • Willis, Fenella;
    • Tighe, Jane;
    • Cook, Gordon;
    • Stirling, Alistair;
    • Bishop, Timothy;
    • Williams, Cathy;
    • Boszczyk, Bronek;
    • Reynolds, Jeremy;
    • Grainger, Mel
    Publication type:
    Article
    30

    Time to redefine Myeloma.

    Published in:
    2015
    By:
    • Pratt, Guy;
    • Bowcock, Stella;
    • Chantry, Andrew;
    • Cook, Gordon;
    • Jackson, Graham;
    • Lai, Maggie;
    • Low, Eric;
    • Mulholland, Nicola;
    • Owen, Roger;
    • Rabin, Neil;
    • Ramasamy, Karthik;
    • Snowden, John A;
    • Streetly, Matthew;
    • Wechalekar, Ashutosh;
    • Yong, Kwee;
    • Bird, Jenny
    Publication type:
    Editorial
    31

    Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUK one randomized dose selection trial.

    Published in:
    British Journal of Haematology, 2015, v. 170, n. 3, p. 336, doi. 10.1111/bjh.13435
    By:
    • Schey, Steve;
    • Brown, Sarah R.;
    • Tillotson, Avie‐Lee;
    • Yong, Kwee;
    • Williams, Cathy;
    • Davies, Faith;
    • Morgan, Gareth;
    • Cavenagh, Jamie;
    • Cook, Gordon;
    • Cook, Mark;
    • Orti, Guillermo;
    • Morris, Curly;
    • Sherratt, Debbie;
    • Flanagan, Louise;
    • Gregory, Walter;
    • Cavet, James
    Publication type:
    Article
    32

    Updates to the guidelines for the diagnosis and management of multiple myeloma.

    Published in:
    British Journal of Haematology, 2014, v. 167, n. 1, p. 131, doi. 10.1111/bjh.12926
    By:
    • Pratt, Guy;
    • Jenner, Matthew;
    • Owen, Roger;
    • Snowden, John A.;
    • Ashcroft, John;
    • Yong, Kwee;
    • Feyler, Sylvia;
    • Morgan, Gareth;
    • Cavenagh, Jamie;
    • Cook, Gordon;
    • Low, Eric;
    • Stern, Simon;
    • Behrens, Judith;
    • Davies, Faith;
    • Bird, Jennifer
    Publication type:
    Article
    33

    Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.

    Published in:
    British Journal of Haematology, 2014, v. 166, n. 1, p. 109, doi. 10.1111/bjh.12861
    By:
    • Jackson, Graham H.;
    • Morgan, Gareth J.;
    • Davies, Faith E.;
    • Wu, Ping;
    • Gregory, Walter M.;
    • Bell, Sue E.;
    • Szubert, Alexander J.;
    • Navarro Coy, Nuria;
    • Drayson, Mark T.;
    • Owen, Roger G.;
    • Feyler, Sylvia;
    • Ashcroft, Andrew J.;
    • Ross, Fiona M.;
    • Byrne, Jennifer;
    • Roddie, Huw;
    • Rudin, Claudius;
    • Boyd, Kevin D.;
    • Osborne, Wendy L.;
    • Cook, Gordon;
    • Child, J. Anthony
    Publication type:
    Article
    34
    35
    36

    Haematopoietic stem cell transplantation ( HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation ( BSBMT) data registry 1997-2009.

    Published in:
    British Journal of Haematology, 2012, v. 157, n. 6, p. 742, doi. 10.1111/j.1365-2141.2012.09122.x
    By:
    • Snowden, John A.;
    • Pearce, Rachel M.;
    • Lee, Julia;
    • Kirkland, Keiren;
    • Gilleece, Maria;
    • Veys, Paul;
    • Clark, Richard E.;
    • Kazmi, Majid;
    • Abinun, Mario;
    • Jackson, Graham H.;
    • Mackinnon, Stephen;
    • Russell, Nigel H.;
    • Cook, Gordon
    Publication type:
    Article
    37
    38

    Guidelines for the diagnosis and management of multiple myeloma 2011.

    Published in:
    British Journal of Haematology, 2011, v. 154, n. 1, p. 32, doi. 10.1111/j.1365-2141.2011.08573.x
    By:
    • Bird, Jennifer M.;
    • Owen, Roger G.;
    • D'Sa, Shirley;
    • Snowden, John A.;
    • Pratt, Guy;
    • Ashcroft, John;
    • Yong, Kwee;
    • Cook, Gordon;
    • Feyler, Sylvia;
    • Davies, Faith;
    • Morgan, Gareth;
    • Cavenagh, Jamie;
    • Low, Eric;
    • Behrens, Judith
    Publication type:
    Article
    39

    Re-transplantation after bortezomib-based therapy.

    Published in:
    British Journal of Haematology, 2011, v. 153, n. 5, p. 666, doi. 10.1111/j.1365-2141.2010.08521.x
    By:
    • Morris, Curly;
    • Cook, Gordon;
    • Streetly, Matthew;
    • Kettle, Paul;
    • Drake, Mary;
    • Quinn, Michael;
    • Cavet, Jim;
    • Tighe, Jane;
    • Kazmi, Majit;
    • Ashcroft, John;
    • Cook, Mark;
    • Snowden, John;
    • Olujohungbe, Ade;
    • Marshall, Scott;
    • Conn, Jane;
    • Oakervee, Heather;
    • Popat, Rakesh;
    • Cavenagh, Jamie
    Publication type:
    Article
    40

    Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease.

    Published in:
    British Journal of Haematology, 2011, v. 153, n. 2, p. 244, doi. 10.1111/j.1365-2141.2011.08615.x
    By:
    • Shaw, Bronwen E.;
    • Apperley, Jane F.;
    • Russell, Nigel H.;
    • Craddock, Charles;
    • Liakopoulou, Effie;
    • Potter, Michael N.;
    • Wynn, Robert;
    • Gibson, Brenda;
    • Pearce, Rachel M.;
    • Kirkland, Keiren;
    • Lee, Julia;
    • Madrigal, J. Alejandro;
    • Cook, Gordon;
    • Byrne, Jennifer L.
    Publication type:
    Article
    41
    42
    43
    44
    45

    Radiocarbon Releases from the 2011 Fukushima Nuclear Accident.

    Published in:
    Scientific Reports, 2016, p. 36947, doi. 10.1038/srep36947
    By:
    • Xu, Sheng;
    • Cook, Gordon T.;
    • Cresswell, Alan J.;
    • Dunbar, Elaine;
    • Freeman, Stewart P. H. T.;
    • Hou, Xiaolin;
    • Jacobsson, Piotr;
    • Kinch, Helen R.;
    • Naysmith, Philip;
    • Sanderson, David C. W.;
    • Tripney, Brian G.
    Publication type:
    Article
    46
    47
    48

    The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trial.

    Published in:
    2018
    By:
    • Striha, Alina;
    • Ashcroft, A. John;
    • Hockaday, Anna;
    • Cairns, David A.;
    • Boardman, Karen;
    • Jacques, Gwen;
    • Williams, Cathy;
    • Snowden, John A.;
    • Garg, Mamta;
    • Cavenagh, Jamie;
    • Yong, Kwee;
    • Drayson, Mark T.;
    • Owen, Roger;
    • Cook, Mark;
    • Cook, Gordon
    Publication type:
    journal article
    49
    50